Finance

Beta
Lists
ZBH:NYSE
Zimmer Biomet Holdings, Inc
USD 93,75
+4,00%
(+3,61) 1D
USD 93,00
-0,80% (-0,75)
After hours
Closed: 16 Jul., 16:02:45 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZBH...
Open
USD 91,49
High
USD 94,08
Low
USD 91,14
Mkt. cap
18,14 mjd
Avg. vol.
2,27 m
Volume
2,87 m
Dividend
1,02%
Quarterly dividend
USD 0,24
Ex-dividend date
25 Jun. 2026
P/E ratio
24,35
52-wk high
USD 108,29
52-wk low
USD 79,12
EPS
USD 3,85
Beta
0,46
Shares outstanding
193,46 m
No. of employees
17 k
Open
USD 91,49
High
USD 94,08
Low
USD 91,14
Mkt. cap
18,14 mjd
Avg. vol.
2,27 m
Volume
2,87 m
Dividend
1,02%
Quarterly dividend
USD 0,24
Ex-dividend date
25 Jun. 2026
P/E ratio
24,35
52-wk high
USD 108,29
52-wk low
USD 79,12
EPS
USD 3,85
Beta
0,46
Shares outstanding
193,46 m
No. of employees
17 k
News stories
From sources across the web
Profile
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook. Wikipedia
About Zimmer Biomet Holdings, Inc
CEOIvan Tornos
Employees17 k
Founded1927
HeadquartersWarsaw, Indiana, Verenigde State van Amerika
SectorMedical device
Websitezimmerbiomet.com
Analyst ratings
Based on 17 analysts giving stock ratings to ZBH in the past 3 months
Hold
Buy
5
Hold
11
Sell
1
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for ZBH in the last 3 months.
Highest
Current USD 93,75
USD 110,00 (+17,33%)
Average
USD 97,43 (+3,93%)
Lowest
USD 83,00 (-11,47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Shagun Singh Chadha
RBC Capital
Buy
Maintained
USD 101,00
+7,7%
07/13/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
07/10/2026
Unknown Analyst
BMO Capital
Hold
Initiated
USD 95,00
+1,3%
07/09/2026
Vik Chopra
BMO Capital
Hold
Initiated
USD 95,00
+1,3%
07/09/2026
Joanne Wuensch
Citi
Hold
Maintained
USD 93,00
-0,8%
07/08/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
USD 110,00
+17,3%
07/06/2026
Caitlin Roberts
Canaccord Genuity
Hold
Maintained
USD 83,00
-11,5%
06/30/2026
Mathew Blackman
TD Cowen
Buy
Maintained
USD 109,00
+16,3%
06/25/2026
Travis Steed
Bank of America Securities
Hold
Reiterated
USD 100,00
+6,7%
06/12/2026
Larry Biegelsen
Wells Fargo
Hold
Reiterated
USD 90,00
-4%
06/01/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
04/29/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
USD 95,00
+1,3%
04/29/2026
Richard Newitter
Truist Financial
Hold
Reiterated
USD 92,00
-1,9%
04/29/2026
Caitlin Cronin
Canaccord Genuity
Hold
Reiterated
USD 83,00
-11,5%
04/29/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
USD 105,00
+12%
04/29/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
USD 92,00
-1,9%
04/29/2026
David Turkaly
Citizens JMP
Buy
Maintained
USD 105,00
+12%
04/29/2026
Matt Miksic
Barclays
Sell
Maintained
USD 94,00
+0,3%
04/29/2026
Michael Matson
Needham
Hold
Maintained
-
-
04/28/2026
Mike Kratky
Leerink Partners
Hold
Initiated
USD 101,00
+7,7%
04/13/2026
Danielle Antalffy
UBS
Sell
Maintained
USD 89,00
-5,1%
02/11/2026
David Roman
Goldman Sachs
Sell
Maintained
USD 88,00
-6,1%
02/10/2026
Patrick Wood
Morgan Stanley
Hold
Maintained
USD 100,00
+6,7%
02/02/2026
Last report
28 Apr. 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
USD 2,09 / USD 1,86
+12,21%beat
Revenue / Est. (USD)
2,09 mjd / 2,07 mjd
+0,83%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
2,08 mjd
2,00 mjd
2,24 mjd
2,09 mjd
Cost of goods sold
590,70 m
559,30 m
795,50 m
564,20 m
Cost of revenue
590,70 m
559,30 m
795,50 m
564,20 m
Research and development expenses
113,30 m
115,90 m
118,70 m
103,40 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
807,20 m
809,40 m
838,50 m
846,20 m
Operating expense
1,08 mjd
1,10 mjd
1,13 mjd
1,11 mjd
Total operating expenses
1,67 mjd
1,66 mjd
1,93 mjd
1,68 mjd
Operating income
405,50 m
340,30 m
313,40 m
410,80 m
Other non operating income
3,60 m
6,20 m
15,10 m
5,50 m
EBT including unusual items
224,60 m
279,20 m
97,90 m
301,30 m
EBT excluding unusual items
327,80 m
269,30 m
250,00 m
340,20 m
Income tax expense
71,20 m
48,00 m
-39,90 m
63,00 m
Effective tax rate
31,70%
17,19%
-40,76%
20,91%
Other operating expenses
-
-
-
-
Net income
152,80 m
230,90 m
139,30 m
238,10 m
Net profit margin
7,36%
11,54%
6,21%
11,41%
Earnings per share
2,07
1,90
2,42
2,09
Interest and investment income
-
-
-
-
Interest expense
-79,30 m
-75,40 m
-71,90 m
-68,80 m
Net interest expenses
-79,30 m
-75,40 m
-71,90 m
-68,80 m
Depreciation and amortization charges
-
-
-
-
EBITDA
677,30 m
623,90 m
597,40 m
680,80 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer